These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28720188)

  • 1. The Importance of the Study of Cognitive Performance Enhancement for U.S. National Security.
    Malish RG
    Aerosp Med Hum Perform; 2017 Aug; 88(8):773-778. PubMed ID: 28720188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroscience, ethics, and national security: the state of the art.
    Tennison MN; Moreno JD
    PLoS Biol; 2012; 10(3):e1001289. PubMed ID: 22448146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues in the use of cognitive enhancement.
    Darby R
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376
    [No Abstract]   [Full Text] [Related]  

  • 4. Military medical research on cognitive performance: the warfighter's competitive edge.
    Schoomaker EB
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B4-6. PubMed ID: 17547298
    [No Abstract]   [Full Text] [Related]  

  • 5. U.S. Army Research on Pharmacological Enhancement of Soldier Performance: Stimulants, Anabolic Hormones, and Blood Doping.
    Friedl KE
    J Strength Cond Res; 2015 Nov; 29 Suppl 11():S71-6. PubMed ID: 26506202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and ethics of cosmetic neurology far from settled.
    Flower K; Li L; Chen CY; Baggott MJ; Galloway GP; Mendelson J
    Clin Pharmacol Ther; 2010 Oct; 88(4):461-3. PubMed ID: 20856245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should one use medications in combination with cognitive training? If so, which ones?
    Yesavage J; Hoblyn J; Friedman L; Mumenthaler M; Schneider B; O'Hara R
    J Gerontol B Psychol Sci Soc Sci; 2007 Jun; 62 Spec No 1():11-8. PubMed ID: 17565161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people.
    Ilieva I; Boland J; Farah MJ
    Neuropharmacology; 2013 Jan; 64():496-505. PubMed ID: 22884611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterproductive criminal rehabilitation: Dealing with the double-edged sword of moral bioenhancement via cognitive enhancement.
    Shaw E
    Int J Law Psychiatry; 2019; 65():101378. PubMed ID: 30206004
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromodulation research and application in the U.S. Department of Defense.
    Nelson JT; Tepe V
    Brain Stimul; 2015; 8(2):247-52. PubMed ID: 25468072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ready or not: enhancing operational effectiveness through use of readiness measures.
    Cosenzo KA; Fatkin LT; Patton DJ
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B96-106. PubMed ID: 17547310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroethics of pharmaceutical cognitive enhancement: the first ten years: current problems and practical guiding principles].
    Metzinger TK
    Fortschr Neurol Psychiatr; 2012 Jan; 80(1):36-43. PubMed ID: 22234814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USAFSAM Aeromedical Consultation Service Medical Risk Assessment and Airworthiness Matrix.
    Mayes RS; Keirns CJ; Hicks AG; Menner LD; Lee MS; Wagner JH; Baltzer RL
    Aerosp Med Hum Perform; 2023 Jul; 94(7):514-522. PubMed ID: 37349922
    [No Abstract]   [Full Text] [Related]  

  • 15. Dealing with requests for pharmacological cognitive enhancement from healthy students.
    Chandramouleeswaran S; Edwin NC; Rajaleelan W
    Indian J Med Ethics; 2016; 1(3):196. PubMed ID: 27474703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing team performance in network-centric operations: philosophical and methodological issues.
    Bolia RS; Nelson WT
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B71-6. PubMed ID: 17547307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive monitors: toward the prevention of cognitive performance decrements and catastrophic failures in the operational environment.
    Thomas ML; Russo MB
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B144-52. PubMed ID: 17547315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operational processes and cognitive mapping.
    Fiedler ER
    Aviat Space Environ Med; 2005 Jul; 76(7 Suppl):C4-6. PubMed ID: 16018322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilots' Attention Distributions Between Chasing a Moving Target and a Stationary Target.
    Li WC; Yu CS; Braithwaite G; Greaves M
    Aerosp Med Hum Perform; 2016 Dec; 87(12):989-995. PubMed ID: 28323583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.